Stay updated on Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The study record for pembrolizumab combined with radiotherapy or ablation in metastatic colorectal cancer is available, with detailed trial design, participant criteria, outcome measures, and study documents. The record also shows that the study is completed and no longer recruiting.
    Difference
    50%
    Check dated 2026-11-11T01:22:42.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-03T23:34:38.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    An NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page. The footer revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:17:53.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The footer’s site revision identifier was updated from v3.7.0 to v3.7.1 while the study page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:11:59.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Access to the study details is blocked by a 403 Forbidden error, preventing viewing the page content. The Home navigation link has been removed from the page's footer/navigation.
    Difference
    0.5%
    Check dated 2026-09-29T23:30:48.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden page, replacing the previous study content. The 403 page shows the standard header and footer and communicates restricted access to the record.
    Difference
    19%
    Check dated 2026-09-22T23:28:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page.